Oxymetholone 50 mg

Oxymetholone 50 mg contains oxymetholone, an oral anabolic-androgenic steroid. In medical practice, it is FDA-approved for the treatment of anemias caused by deficient red cell production, including acquired aplastic anemia, congenital aplastic anemia, and myelofibrosis. In non-medical bodybuilding settings, it is commonly referenced for rapid gains in muscle mass and strength, though such use falls outside approved medical indications.

In medical settings, oxymetholone is typically dosed at 1 to 5 mg per kg of body weight daily, often divided into two or three doses. In non-medical bodybuilding contexts, it is commonly referenced at 50–100 mg per day, often taken as a single dose or divided, for cycle durations of 4–6 weeks.

Yes, oxymetholone suppresses endogenous testosterone production, and post-cycle therapy is commonly referenced in non-medical contexts to support hormonal recovery. Agents such as Nolvadex 20 mg or Clomid 50 mg are SERMs commonly referenced for this purpose. PCT protocols vary based on cycle length and individual factors.

Oxymetholone binds to androgen receptors in muscle tissue, stimulating protein synthesis and nitrogen retention. It also enhances erythropoietin production, which stimulates red blood cell production and can improve oxygen delivery to muscles. It is a 17-alpha-alkylated compound, which makes it orally bioavailable but also hepatotoxic.

In medical settings for anemia, response to oxymetholone may not be immediate, and a minimum trial of 3 to 6 months is recommended. In non-medical bodybuilding contexts, users commonly report noticeable increases in strength and muscle fullness within the first one to two weeks of a cycle. Individual response varies based on dosage, training, and nutrition.

There is no single oral steroid that is universally best. Oxymetholone is known for its potent anabolic effects and rapid mass gains, but it also carries significant hepatotoxic and cardiovascular risks. Other compounds such as Anavar 20 mg offer a different risk-benefit profile. The appropriate choice depends on individual goals, health status, and risk tolerance.

Oxymetholone and Dianabol (methandienone) are both oral AAS often referenced for bulking, but they have different profiles. Oxymetholone is a non-aromatizing compound that does not convert to estrogen. Dianabol 25 mg is an aromatizing compound that can produce estrogenic side effects such as water retention and gynecomastia. Both are 17-alpha-alkylated and carry hepatotoxic potential.

Oxymetholone and Anavar (oxandrolone) are both oral AAS, but they have different characteristics. Oxymetholone is known for rapid mass and strength gains, while Anavar 20 mg contains oxandrolone, which is often referenced for lean muscle preservation during cutting phases. Both are 17-alpha-alkylated and carry hepatotoxic potential, though oxymetholone is generally considered more potent and more hepatotoxic.

In medical settings, oxymetholone doses are calculated by body weight at 1 to 5 mg per kg daily, which for many adults could exceed 50 mg daily. In non-medical bodybuilding contexts, 50 mg per day represents a common starting dose, with ranges commonly referenced at 50–100 mg daily. However, any use outside medical supervision carries significant risks, and individual response varies.

Oxymetholone 50 mg is labeled at 50 mg of oxymetholone per tablet. It is supplied as 100 oral tablets per package, giving 5,000 mg of total labeled content.

No published laboratory report is available for this specific Oxymetholone 50 mg product at this time. Laboratory testing of anabolic steroid products can provide information about potency and purity, but such testing is separate from clinical monitoring of individuals using these compounds.

Community consensus in non-medical contexts generally recommends limiting oxymetholone cycles to 4–6 weeks due to hepatotoxicity concerns. Medical labeling notes that cholestatic hepatitis and jaundice occur with 17-alpha-alkylated androgens at relatively low doses, and continued therapy has been associated with hepatic coma and death. Longer cycles increase the risk of liver strain and other adverse effects.